Biotech Values

[masterlongevity]

when the market turn around, i bet we will see 30-40 new biotechs pop up in the bay area from people leaving genentech.

I actually think buying genentech is a bad long term deal for Roche. As a former employee and a friend with many current employees, i would venture that 40-50% of current R&D employees will leave over the next 3 yrs.